phs000280.v5.p1
Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000007.v30.p11
Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy
Mapping250K_Nsp
Mapping250K_Sty
Mapping50K_Hind240
Mapping50K_Xba240
|
phs000228.v4.p1
HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium
454 GS FLX Titanium
|
phs000090.v4.p1
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000209.v13.p3
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000086.v3.p1
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0
ILLUMINA_Human_1M
|
phs000095.v3.p1
Dental Caries GWAS | Versions 1-3: passed embargo
| VDAS | 5418 | Nuclear Families, Parent-Offspring Trios, Case-Control | | Human610_Quadv1_B
|
phs001073.v1.p1
Epigenetic Analysis of Malnutrition | Version 1: passed embargo
| VDAS | 59 | Interventional, Randomized, Clinical Trial | | TruSeq ChIP
|
phs000236.v2.p2
PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA) | Versions 1-2: passed embargo
| VDAS | 3595 | Longitudinal | Links | TaqMan OpenArrays: CALiCo ABD TaqMan Y1
TaqMan OpenArrays: CALiCo ABD TaqMan Y2
TaqMan OpenArrays: CALiCo AOD TaqMan Y1
TaqMan OpenArrays: CALiCo AOD TaqMan Y2
TaqMan OpenArrays: CALiCo DME TaqMan Y1
TaqMan OpenArrays: CALiCo DME TaqMan Y2
TaqMan OpenArrays: CALiCo Sequenom Y2
iSelect Custom Panel
|
phs000096.v4.p1
HAPO Maternal Glycemia and Birthweight GEI Study | Versions 1-4: passed embargo
| VDAS | 9987 | Prospective, Observational, Cohort | Links | Human1M-Duov3_B
Human610_Quadv1_B
HumanOmni1-Quad_v1-0_B
|
phs000092.v1.p1
Study of Addiction: Genetics and Environment (SAGE) | Version 1: passed embargo
| VDAS | 4121 | Case-Control | Links | ILMN_Human-1
|
phs000168.v2.p2
NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci | Versions 1-2: passed embargo
| VDAS | 5220 | Family, Longitudinal, Case-Control | Links | Human610_Quadv1_B
|
phs000160.v1.p1
Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project) | Version 1: passed embargo
| VDAS | 2398 | Family, Control Set | Links | Linkage-IVb Marker Panel
|
phs000260.v4.p2
Foregut Microbiome in Development of Esophageal Adenocarcinoma | Versions 1-4: passed embargo
| VDAS | 110 | Case-Control | Links | 454 GS FLX Titanium
HiSeq 2000
|
phs000094.v1.p1
International Consortium to Identify Genes and Interactions Controlling Oral Clefts | Version 1: passed embargo
| VDAS | 7507 | Case Set, Parent-Offspring Trios | Links | Human610_Quadv1_B
|
phs001309.v1.p1
MICEPAP Trial | Version 1: passed embargo
| VDAS | 159 | Clinical Trial | Links | |
phs000309.v3.p2
The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs001386.v1.p1
Smoking and the Vaginal Microbiome | Version 1: passed embargo
| VDAS | 47 | Case-Control, Longitudinal | | 454 GS FLX Titanium
|
phs000017.v3.p1
Whole Genome Association Study of Bipolar Disorder | Versions 1-3: passed embargo
| VDAS | 3261 | Case-Control | Links | AFFY_6.0
|
phs000605.v1.p1
Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial) | Version 1: passed embargo
| VDAS | 111 | Clinical Trial, Clinical Diagnostic Testing, Randomized Controlled Clinical Trial | Links | |